This will probably contribute to the improvement of asthma control and the prevention of acute exacerbations. Triggers of acute exacerbations are generally hard to avoid. Therefore, preexisting ...
The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.
The Nose Knows: Nasal Swab Detects Asthma Type in Kids Jan. 2, 2025 — A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians ...
18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug. The final appraisal ...
Some healthcare professionals are unaware of the link between the menopause and the potentially-deadly condition, which affects 7.2million people in the UK.